Liver Disease Treatment Market to experience handsome growth during 2022-2028
Liver Disease Treatment Market is segmented by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others), by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).
What is a Liver Disease Treatment Market?
The basic activities of the liver, which is a crucial organ for the body and performs more than 500 different tasks, include the generation and excretion of bile as well as the elimination of bilirubin, cholesterol, hormones, and medications. It purifies and detoxifies the blood while battling infection and poisons. A variety of intricate disorders that affect the liver collectively make up liver disease. A range of acute and chronic illnesses, such as hepatitis A, B, C, non-alcoholic fatty liver disease, liver cancer, bile duct cancer, liver cell adenoma, and liver cirrhosis, can be brought on by liver malfunction, which can be fatal. Hemochromatosis, hyperoxaluria, and Wilson's disease are examples of liver conditions that are inherited.
Market Dynamics
The liver disease treatment market was estimated at US$ 21.71 billion in 2021 and is expected to grow at a CAGR of 6.16% during 2022-2028 to reach US$ 31.2 billion in 2028. About 95.2 thousand people died from alcohol-related causes in 2021, with liver disorders accounting for 31.08% of those fatalities, according to the National Center for Drug Abuse Statistics. The primary killer, responsible for 19.1% of all alcohol-related deaths, is alcoholic liver disease. By providing the proper liver treatment at the appropriate time, such significant mortality can be avoided, which spurs the market's expansion.
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
To get a free sample report, Click here:
https://www.stratviewresearch.com/Request-Sample/3165/liver-disease-treatment-market.html#form
The Liver Disease Treatment Market analysis report discusses the following heads in details:
· Market structure: Overview, industry life cycle analysis, supply chain analysis.
· COVID-19 Impact Assessment.
· Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
· Market trend and forecast analysis.
· Market segment trend and forecast.
· Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
· Attractive market segments and associated growth opportunities.
· Emerging trends.
· Strategic growth opportunities for the existing and new players
· Key success factors.
Regional Analysis
The liver disease treatment market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The region with the highest growth is expected to be Asia-Pacific. The increased demand for therapies for progressive and severe liver disease, particularly in countries like India, China, and South Korea in this area, is largely to blame for the market's expansion.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian